About Conference
Cancer Therapy 2019 America
Conference Series LLC Ltd is organizing Cancer Therapy Conferences in 2019 at San Francisco, USA. We organize Cancer Therapy Meetings in the fields related to Cancer Biology, Brest Cancer, Cancer Treatment Research ,Targeted Therapy, Cancer Metabolism and recent innovations in Cancer Therapies, Nano Paricals in Cancer Therapy , Cancer Biomarkers.
Cancer Science and Therapy conference invites Cancer Specialists, Oncologists, Professors, Directors, Students and Industrial professionals from USA, Europe and Asia. Explore and learn more about Conference Series LLC Ltd: World's leading Event Organizer. Meet Global Oncologists, Doctors, Scientists Researchers and Industry Professionals from UK, Europe, USA, Middle East, and Asia at Cancer Therapy 2019 America .
27thAnnual Congress on Cancer Science and TherapyDate: February 20-21, 2019 San Francisco, USAVenue: San Francisco, USA
Cancer Therapy 2019 America will be organized around the theme "Characterizing Novel Approaches in Cancer Therapies and Diagnosis"
Cancer Therapy 2019 America is comprised of many interactive scientific sessions on different types of Cancer disorders as well as various diagnostic and therapeutic advancements in this field. It is an initiative to unite the diverse research and business communities working in this field under a one roof to explore every single aspect of oncology. Cancer Therapy 2019 America welcomes the Cancer Specialists, Oncologists, Professors, and Directors, Research scholars, Student delegates and Industrial professionals from Biomedical and healthcare sectors to be a part of it in Cancer Therapy 2019 America.
According to market study, annual global growth in the oncology drug market is expected to be 7.5 10.5 percent through 2020, reaching $150 billion. Wider utilization of new products especially immunotherapies will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes. Payers also are expected to tighten their negotiation stance with manufacturers and adopt new payment models in an effort to drive greater value from their expenditures on these drugs.
Cancer Science and Therapy are organized Conference Series LLC Ltd which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. Cancer Therapy 2019 will provide an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster and Live Streaming, B2B and Scientific Meetings.
Why to attend?
Cancer Therapy 2019 America will provide a stimulating scientific environment and a platform for the participants to share ideas and knowledge, collaborate on Cancer and Oncology related problems and network with other professionals. Discussing on various imperative topics will add an insight to ponder and confer over crux of today's scientific and technological perk up. It will be amazing opportunity for the attendees to explore the beautiful City of Los Angeles with gaining knowledge, sure to raise insights, conflate present with future and cogitate on ideas and reality in Oncology meetings. To fight against these hard to cure cancer diseases, Cancer Therapy 2019 has taken this initiative to explore every aspects of Cancer research.
About San Francisco City:
San Francisco, in northern California, is a hilly city on the tip of a peninsula surrounded by the Pacific Ocean and San Francisco Bay. Its known for its year-round fog, iconic Golden Gate Bridge, cable cars and colorful Victorian houses. The Financial Districts Transamerica Pyramid is its most distinctive skyscraper. In the bay sits Alcatraz Island, site of the notorious former prison. San Francisco is home to a little bit of everything. Whether youre a first time visitor or a long-time local, San Franciscos Golden Gates welcome all. This is the place to find out about all things San Francisco. San Francisco may only stretch across 7 miles, but its packed with an assortment of activities thats sure to please outdoorsy types, foodies and curious wanderers of all ages. The Golden Gate Bridge is a must-see, while a visit to Alcatraz Island to tour the infamous and now closed federal prison should also be high on your list. Instead of spending all your time around the touristy Fishermans Wharf, you can discover a more authentic side of San Francisco by grabbing a bite at the Ferry Building Marketplace or with a visit to the vibrant Castro. And whether its climbing to the top of Twin Peaks or sauntering through Golden Gate Park, active types and nature lovers will find plenty to love about San Francisco.
Target Audience
The 27thAnnual conference on Cancer Science and Targeted Therapies is intended for Cancer Specialists, Gynecologic oncologists, Medical oncologists, Radiation oncologists, Obstetricians/gynecologists, fellows and residents, research scientists, nurses, nurse practitioners, physician assistants, allied health professionals, and others involved in the care of patients with Oncologic malignancies.
Learning Objectives
As a result of attending the Annual Conference, learners will be able to:
Interpret contemporary research findings on the prevention of and screening for Cancerous tumours and be able to appropriately implement these findings into clinical practice
Examine the significance of novel approaches to the medical and surgical management of Cancerous tumours within the context of the current standard of care and be able to integrate new therapies into clinical practice in an evidence-based manner
Assess the implications for future research and clinical practice of new developments in translational research on Cancerous tumours.
Demonstrate improvement in competence, performance and patient outcomes and Identify and explain the latest trends in global research, methods, and technology in the treatment of Cancerous tumours.
Cancer is a class of diseases characterized by out-of-control cell growth. There are more than 100 distinct sorts of cancer and each is ordered by the kind of cell which is first influenced. Malignancy is thought to be one of the main sources of grimness and mortality around the world. More than 575,000 individuals bite the dust of tumor and more than 1.5 million individuals are determined to have disease every year in the US. A restorative expert who hones in the field of cancer and cancer related diseases is an oncologist.
In addition to the multidisciplinary talks, keynote sessions and lectures relevant to cancer science & therapy, the Cancer Therapy 2019America is a complete 2 days event with panel discussions, open Q & A to generate a prime learning knowledge between participants.
Scientific Sessions of the Conference includes:
Target Therapy
Cancer Immunotherapy & Vaccines
Cancer Metabolism
Cancer Epigenomics
Cancer Inflammation and Immune Tolerance
Nanoparticles in Cancer Therapy
Novel Approaches to Cancer Therapeutics
Cancer Management & Prevention
Cancer Pharmacology
Tumor Virology
Tumour immunology & immunotherapy
Organ-Specific Cancer
Cancer Biomarkers
Cancer Stem Cell Therapy
Anti-Cancer Agents in Medicinal Chemistry
Surgical Oncology
Cancer: Psychological & Social Aspects
Radiation Oncology
Cancer Chemotherapy
Cancer Diagnostics & Diagnostic Market
Complementary and Alternative Cancer Treatment
Medical Oncology
Mechanisms of Carcinogenesis
Genetic Cancer Susceptibility
Infections and Cancer Epidemiology
Etiology of Cancer
Cancer Treatment Research
Cancer Genetics and genomics
Computational Oncology
Solid Tumour Oncogenesis
1. Target Therapy
Targeted therapy is a special type of chemotherapy involves a mechanism of differentiating between cancerous and non-cancerous cells in the body, attacking only the cancerous ones but not interfering with the normal ones. it is sometimes used alone, but most often other cancer treatments are used in combination with targeted therapy.
Therapeutic Monoclonal Antibodies Small Molecule Drugs Tyrosine-kinase inhibitors Implications of Targeted Therapy Targeted Cancer Therapy & Health Economics Hormone Therapies
2. Cancer Immunotherapy & Vaccines
Cancer immunotherapy (Immuno-oncology or Immunooncology) is the use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid (active and passive). These approaches exploit the fact that cancer cells often have molecules on their surface that can be detected by the immune system, known as tumour-associated antigens (TAAs); they are often proteins or other macromolecules (e.g. carbohydrates). Active immunotherapy directs the immune system to attack tumor cells by targeting TAAs. Passive immunotherapies enhance existing anti-tumor responses and include the use of monoclonal antibodies, lymphocytes and cytokines.
Nano systems Targeted delivery Cell tracking Immunotherapy Tumor biology Cancer vaccines
3.Cancer Metabolism
Cancer metabolism refers to the alterations in cellular metabolism pathways that are evident in cancer cells compared with most normal tissue cells. Metabolic alterations in cancer cells are numerous and include aerobic glycolysis, reduced oxidative phosphorylation and the increased generation of biosynthetic intermediates needed for cell growth and proliferation.
4.Cancer Epigenomics
Cancer epigenetics is the study of epigenetic modifications to the genome of cancer cells that do not involve a change in the nucleotide sequence. Epigenetic alterations are as important as genetic mutations behind the transition of a cell from normal to cancerous, and their manipulation holds great promise for cancer prevention, detection and therapy. In different types of cancer, a variety of epigenetic mechanisms can be perturbed, such as silencing of tumor suppressor genes and activation of oncogenes by altered CpG island methylation patterns, histone modifications and dysregulation of DNA binding proteins.
Cancer genomics Epigenetic influence on genomic stability Molecular underpinnings of therapeutic targets Aberrant DNA methylation genes Tumor heterogeneity
5. Cancer Inflammation and Immune Tolerance
It is widely accepted that chronic inflammation critically contributes to cancer. Immune tolerance in cancer mediates tumor escape from the immune system. Inflammation mediates tumor-induced tolerance. The induction and the maintenance of the chronic inflammatory response is a universal mechanism of immune tolerance.
6. Nanoparticles in Cancer Therapy
Nanoparticles have been of significant interest over the last decade as they offer great benefits in drug delivery to overcome limitations present in case of conventional chemotherapy. They can not only be formed in a range of sizes (1-1000 nm) but also made by using a variety of materials including polymers, lipids, inorganic materials and biological materials. Using targeted nanoparticles to deliver chemotherapeutic agents in cancer therapy, offers many advantages to improve drug/gene delivery and to overcome many problems associated with conventional chemotherapy.
7. Novel Approaches to Cancer Therapeutics
The normal treatment modalities are associated with severe side effects and high toxicity which in turn lead to low quality of life. This review encompasses novel strategies for more effective chemotherapeutic delivery aiming to generate better prognosis. Currently, cancer treatment is a highly dynamic field and significant advances are being made in the development of novel cancer treatment strategies. In contrast to conventional cancer therapeutics, novel approaches such as ligand or receptor based targeting, intracellular drug targeting, gene delivery, cancer stem cell therapy, magnetic drug targeting and ultrasound-mediated drug delivery, have added new modalities for cancer treatment.
Cancer Epigenetics Molecular Profiling Techniques New Biologics & Vaccines Chemical Proteomics Combination Strategies in Immuno-oncology Novel Biomarker Discovery
8. Cancer Management & Prevention
Types of Cancer which are closely linked to certain behaviours are the easiest to prevent. Many complementary health approaches are also found to combat the risks associated with cancer like, for example, herbal and other dietary supplements, acupuncture, massage and yoga.
Lifestyle changes Diet & Cancer Vaccinations Natural Therapy Psychological & Social Aspects
9. Cancer Pharmacology
Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches.
10. Tumor Virology
Since its inception, the field of tumor virology has provided ground-breaking insights into the causes of human cancer. Tumor virologists additionally recognized that viruses could serve as powerful discovery tools, leading to revolutionary breakthroughs in the 1970s and 1980s that included the concept of the oncogene, the identification of the p53 tumor suppressor, and the function of the retinoblastoma tumor suppressor. This rich history promises that tumor virology will continue to contribute to our understanding of cancer and to the development of new therapeutic and preventive measures for this disease
11. Tumourimmunology & immunotherapy
Tumor Immunology and Immunotherapy focuses on recent advances in understanding the range of immune responses towards cancer and how these can be modified and harnessed for prevention and therapeutics.
12. Organ-Specific Cancer
Malignancy has a differentiated nature in connection to the organ specificity. The essential focus is on heterogeneity, starting point, metastasis, angiogenesis and organ indicated systems in disease cells. There is a diverse spectrum of diseases, taking into account the area of tumor in the body organ. Organ-particular metastasis includes disease cell collaborations with the host micro-environment, including actuation of paracrine cytokine circles, change of the host cell synthesis, and modification of extracellular framework structures.
13. CancerBiomarkers
A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected bio-fluids like blood or serum.
Imaging Biomarkers Clinical Biomarkers Genetic Biomarkers Predictive Cancer Biomarkers Molecular Biomarkers Cell Free Biomarkers
14. Cancer Stem Cell Therapy
Stem cell transplants are procedures that restore blood-forming stem cells in people who have had theirs destroyed by the very high doses of chemotherapy or radiation therapy that are used to treat certain cancers. Blood-forming stem cells are important because they grow into different types of blood cells.
Cancer Stem Cells Stem Cells and Tumors Stem Cell Transplantation Bone Marrow Transplantation Cord Blood Stem Cells and Cancer Stem Cell Research
15. Anti-Cancer Agents in Medicinal Chemistry
Anti-Cancer agents in Medicinal Chemistry aim to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.
16. Surgical Oncology
Surgical oncology is a specialty that focuses on the surgical treatment of a variety of tumors. Ephraim McDowell did the first reported resection of an ovarian tumor in 1809, but as early as the 7th century, ancient Egyptians described techniques for removing breast tumors.
17. Cancer: Psychological & Social Aspects
Cancer treatments today are likely to cause less physical deformity from surgery than a half-century ago, but are more complex and extend over a longer period of time. People today are often well informed about the details of their cancer diagnosis and prognosis, and are increasingly involved in shared decision-making regarding treatment. Although serious depression is not seen in the majority of cancer patients and survivors, many will experience treatment-related distress, fear of recurrence, changes in body image and sexuality, as well as physical toxicities that result from adjuvant therapy. It is important to identify the psychological and social concerns of cancer patients in the medical setting, and assisting them in obtaining appropriate psychosocial services.
18. Radiation Oncology
Radiation oncology is a medical speciality that involves the controlled use of radiation to treat cancer either for cure, or to reduce pain and other symptoms caused by cancer. Radiation therapy (also called radiotherapy) is the term used to describe the actual treatment delivered by the radiation oncology team.
19. Cancer Chemotherapy
Read this article:
Cancer therapy Conferences 2019 | Oncology Meetings ...